Neuronetics Inc. (STIM)
NASDAQ · Healthcare
Neuronetics Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Neuronetics Inc. shareholder equity for the quarter ending December 31, 2025 were 22.4M, a 19.23% decrease year-over-year.
- Neuronetics Inc. shareholder equity for 2025 were 22.4M, a 19.23% decrease from 2024.
- Neuronetics Inc. shareholder equity for 2024 were 27.7M, a 18.96% decrease from 2023.
- Neuronetics Inc. shareholder equity for 2023 were 34.2M, a 40.08% decrease from 2022.
- Neuronetics Inc. shareholder equity for 2022 were 57.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Neuronetics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $22 |
| 2024 | $28 |
| 2023 | $34 |
| 2022 | $57 |
| 2021 | $85 |
| 2020 | $25 |
| 2019 | $48 |
| 2018 | $71 |
| 2017 | $-193 |
| Neuronetics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $22 |
| 2024-12-31 | $28 |
| 2023-12-31 | $34 |
| 2022-12-31 | $57 |
| 2021-12-31 | $85 |
| 2020-12-31 | $25 |
| 2019-12-31 | $48 |
| 2018-12-31 | $71 |
| 2017-12-31 | $-193 |
Neuronetics Inc. Shareholder Equity — FAQ
Neuronetics Inc. (STIM) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STIM's shareholder equity history?
The chart and table above show Neuronetics Inc.'s shareholder equity by year and by quarter, including the growth rate.